| 31 Aug, 10:36 pm | other | 0 | Onesource Specialty Pharma Limited has informed the Exchange regarding the submission of its Business Responsibility and Sustainability Report (BRSR) for FY 25-26. | nse |
| 31 Aug, 08:32 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Reg. 34 (1) Annual Report. | bse |
| 31 Aug, 08:30 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Reg. 34 (1) Annual Report. | bse |
| 18 Aug, 01:17 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Credit Rating | nse |
| 18 Aug, 12:23 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 31 Jul, 12:55 pm | — | … | OneSource Specialty Pharma Limited has informed the Exchange about Earnings Call Transcript dated July 25, 2026 | nse |
| 31 Jul, 12:44 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 27 Jul, 07:04 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about change in Management | nse |
| 27 Jul, 06:56 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 25 Jul, 03:02 pm | — | … | OneSource Specialty Pharma Limited has informed the Exchange about Link of Recording | nse |
| 24 Jul, 10:39 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding 'Allotment of ESOPs'. | nse |
| 24 Jul, 09:19 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated July 24, 2026, titled "OneSource announces strong Q1FY27 results Revenue up 37% YoY and EBITDA up 39% YoY". | nse |
| 24 Jul, 09:11 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Jul, 07:51 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about change in Management of the Company | nse |
| 24 Jul, 07:46 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 24 Jul, 07:03 pm | — | … | Onesource Specialty Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 24 Jul, 06:58 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Board Meeting Outcome for Intimation Of The Outcome Of The Board Meeting Dated July 24, 2026, For The Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026 | bse |
| 20 Jul, 06:23 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30, 2026. | bse |
| 14 Jul, 10:02 am | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding 'OneSource Specialty Pharma and Formycon AG announceStrategic Manufacturing Partnership for Biosimilars'. | nse |
| 09 Jul, 10:49 am | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding 'Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015'. | nse |
| 08 Jul, 06:43 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about allotment of ESOPs | nse |
| 02 Jul, 04:21 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding 'Completion of US-FDA Inspection at Sterile Product Division facility at Bengaluru'. | nse |
| 17 Jun, 01:03 pm | — | … | Tenshi Pharmaceuticals Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 19 May, 06:53 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Earnings Call Transcript dated May 13, 2026. | nse |
| 19 May, 06:37 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 19 May, 10:55 am | — | … | In furtherance to the clarification sought by the exchange with regard to the OCR readable format of the financial results, Onesource Specialty Pharma Limited has submitted the OCR Readable financial results for the quarter and year ended March 31, 2026 | nse |
| 19 May, 10:49 am | — | … | In furtherance to the intimation made on May 13, 2026, w.r.t the resignation of the SMP, Onesource Specialty Pharma Limited has informed the Exchange regarding resignation document of SMP. | nse |
| 19 May, 10:44 am | — | … | Onesource Specialty Pharma Ltd - 544292 - General- Update | bse |
| 16 May, 01:15 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding the receipt of in-principle approval from the Government of Karnataka for the application submittedby the Company for its Unit II expansion project under the Karnataka Industrial Policy (KIP) 2025 30, towards incentives and concessions.'. | nse |
| 16 May, 01:13 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - General-Update | bse |
| 14 May, 07:17 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about publication of Newspaper Advertisement - Extract of Audited Standalone and Conslidated Financial Results for the quater and year ended March 31, 2026. | nse |
| 13 May, 06:07 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Link of Recording | nse |
| 13 May, 01:46 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 May, 01:41 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 13 May, 01:40 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated May 13, 2026, titled "OneSource Announces FY26 Results with Strong Q4 Performance;Reaffirms FY28 Guidance". | nse |
| 13 May, 01:29 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 13 May, 01:28 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange Update on Composite Scheme of Arrangement and Amalgamation (Merger by Absorption) amongstSteriscience Specialties Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, Strides Pharma Services Private Limited and Onesource Specialty Pharma Limited and their respective shareholders (under section 230 to 232 read with section 234, section 52, section 66 of the Indian Companies Act and under section 210 read with section | nse |
| 13 May, 01:25 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | bse |
| 13 May, 01:18 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding Change in Auditors of the company. | nse |
| 13 May, 01:17 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about allotment of ESOPS | nse |
| 13 May, 01:12 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 13 May, 01:09 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding Resignation of Prateek Gupta as (SVP & Head Technical Development) of the company w.e.f. May 13, 2026. | nse |
| 13 May, 01:04 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Board Meeting Outcome for Intimation Of The Outcome Of The Board Meeting Dated May 13, 2026 For Approval Of The Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2026 | bse |
| 13 May, 12:59 pm | — | … | Onesource Specialty Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 07 May, 06:48 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 | bse |
| 04 May, 08:28 am | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated May 04, 2026, titled "OneSource Supports Second Generic Semaglutide Approval in Canada-Enables commercialisation for the first two entrants in the world s second-largest semaglutide market". | nse |
| 04 May, 08:27 am | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Apr, 09:33 am | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated April 29, 2026, titled "OneSource s Partner Dr. Reddy's Laboratories receives Health Canada Approval for Generic Semaglutide Injection". | nse |
| 29 Apr, 09:31 am | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 28 Apr, 09:21 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about General Updates | nse |